Compounds > ciprofloxacin

ciprofloxacin and abt 492

ciprofloxacin has been researched along with abt 492 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's1 (9.09)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
Betson, M; Bingham, M; Doyle, P; Hallworth, S; Harvey, R; Huxley, A; Kirk, R; Moat, J; Nelson, G; Pesnot, T; Tait, M1
Akaki, T; Kajitani, H; Sato, K; Shishido, S; Tomioka, H1
Almer, LS; Balli, DJ; Beyer, JM; Cai, Y; Flamm, RK; Hensey-Rudloff, D; Nilius, AM; Shen, LL1
Andrews, JM; Brenwald, NP; Fraise, AP; Harnett, SJ; Jevons, G; Wise, R1
Alferova, IV; Firsov, AA; Lubenko, IY; Portnoy, YA; Vostrov, SN; Zinner, SH1
Alferova, IV; Firsov, AA; Lubenko, IY; Portnoy, YA; Smirnova, MV; Zinner, SH1
Crandon, JL; Nicolau, DP; So, W1
McCaughan, J; Millar, BC; Moore, JE; Rendall, JC1
Brown Elliott, BA; Wallace, RJ1
McCurdy, SP; Schweizer, HP; Somprasong, N1
Babyak, AL; Cote, CK; Halasohoris, SA; Hickman, M; Hoover, R; Klimko, CP; Lembirik, S; McCurdy, S; Meinig, JM; Scarff, J1

Other Studies

11 other study(ies) available for ciprofloxacin and abt 492

ArticleYear
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections.
    Bioorganic & medicinal chemistry letters, 2020, 10-15, Volume: 30, Issue:20

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbon; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Structure-Activity Relationship

2020
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: 4-Quinolones; Aminopyridines; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Rifamycins

2000
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Blood Proteins; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Protein Binding; Quinolones; Rats

2003
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Quinolones

2004
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:2

    Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Half-Life; Humans; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Quinolones

2004
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:5

    Topics: Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Computer Simulation; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Streptococcus pneumoniae; Time Factors

2005
Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    The Journal of urology, 2015, Volume: 194, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinalysis; Urinary Tract Infections; Urine; Young Adult

2015
Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.
    The clinical respiratory journal, 2021, Volume: 15, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Cystic Fibrosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2021
Comparison of
    Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7

    Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria

2021
Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel.
    Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5

    Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests

2022
Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.
    The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Mice; Microbial Sensitivity Tests

2023